ES2043689T3 - Procedimiento para la inactivacion de germenes patogenos filtrables capaces de reproducirse. - Google Patents

Procedimiento para la inactivacion de germenes patogenos filtrables capaces de reproducirse.

Info

Publication number
ES2043689T3
ES2043689T3 ES87890116T ES87890116T ES2043689T3 ES 2043689 T3 ES2043689 T3 ES 2043689T3 ES 87890116 T ES87890116 T ES 87890116T ES 87890116 T ES87890116 T ES 87890116T ES 2043689 T3 ES2043689 T3 ES 2043689T3
Authority
ES
Spain
Prior art keywords
filtrable
inactivation
reproduce
procedure
pathogenic germs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87890116T
Other languages
English (en)
Inventor
Johann Dr Eibl
Yendra Dr Linnau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG filed Critical Immuno AG
Application granted granted Critical
Publication of ES2043689T3 publication Critical patent/ES2043689T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Optical Filters (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Networks Using Active Elements (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EN UN PROCEDIMIENTO PARA LA INACTIVACION DE AGENTES PATOGENOS, CAPACES DE REPRODUCCION, FILTRABLES, EN FRACCIONES QUE CONTIENEN INMUNOGLOBULINA G, UTILIZABLES TERAPEUTICA O PROFILACTICAMENTE, SE OBTIENE, PARA MANTENER LA ACTIVIDAD COMPLETA DE LOS PRODUCTOS SANGUINEOS, Y PARA LA INACTIVACION COMPLETA DE LOS VIRUS PATOGENOS, UNA SOLUCION ACUOSA DE UNA FRACCION CONTENIENDO INMUNOGLOBULINA G, OBTENIDA A PARTIR DE SANGRE HUMANA, SE TRATA A UNA TEMPERATURA DE 4 A 50 (GRADOS) C Y EN UN VALOR PH DE 5,5 A 9,5, CON HIDROLASAS NEUTRAS.
ES87890116T 1986-05-30 1987-05-21 Procedimiento para la inactivacion de germenes patogenos filtrables capaces de reproducirse. Expired - Lifetime ES2043689T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0145786A AT390560B (de) 1986-05-30 1986-05-30 Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern

Publications (1)

Publication Number Publication Date
ES2043689T3 true ES2043689T3 (es) 1994-01-01

Family

ID=3514329

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87890116T Expired - Lifetime ES2043689T3 (es) 1986-05-30 1987-05-21 Procedimiento para la inactivacion de germenes patogenos filtrables capaces de reproducirse.

Country Status (8)

Country Link
US (1) US4814277A (es)
EP (1) EP0247998B1 (es)
JP (1) JP2506370B2 (es)
AT (2) AT390560B (es)
CA (1) CA1340062C (es)
DE (1) DE3786838D1 (es)
DK (1) DK272287A (es)
ES (1) ES2043689T3 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK166763B1 (da) * 1983-03-16 1993-07-12 Immuno Ag Immunoglobulin-g-holdig fraktion
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
AT396937B (de) * 1992-04-06 1993-12-27 Immuno Ag Verfahren zur aktivierung von blutgerinnungsfaktoren
EP0706400A1 (en) * 1993-03-15 1996-04-17 Pharma Pacific Pty. Ltd. Therapeutic formulation and method
AU673589B2 (en) * 1993-03-15 1996-11-14 Pharma Pacific Pty Ltd Therapeutic formulation and method
DE4424935C1 (de) 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
DE19600939C1 (de) 1996-01-12 1997-08-28 Immuno Ag Verfahren zur Trennung von IgG und IgA
WO1998009660A1 (en) * 1996-09-06 1998-03-12 Epic Therapeutics, Inc. Viral inactivation of biological fluids with biomolecule activity retention
AT405135B (de) 1997-01-17 1999-05-25 Immuno Ag Präparation umfassend thiolgruppen-hältige proteine
AT404358B (de) 1997-02-04 1998-11-25 Immuno Ag Verfahren zur chromatographischen reinigung bzw. fraktionierung von von willebrand-faktor aus einem vwf-hältigen ausgangsmaterial
AT405485B (de) * 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT410218B (de) 1999-08-20 2003-03-25 Baxter Ag Verfahren zur herstellung eines qualitätsgesicherten pools biologischer proben
AU2008286361B2 (en) 2007-08-13 2013-09-26 Takeda Pharmaceutical Company Limited IVIG modulation of chemokines for treatment of multiple sclerosis, Alzheimer's disease, and Parkinson's disease
DK2820042T3 (da) 2012-02-29 2019-10-28 Baxalta GmbH Igg-stimuleret remyelinisering af perifere nerver

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2065196A (en) * 1934-10-09 1936-12-22 Parfentjev Ivan Alexandrovich Method for purification of antitoxins and the like
JPS5195125A (ja) * 1975-02-19 1976-08-20 Jomyakuchushayomenekiguroburinno seizoho
DE2835843A1 (de) * 1978-08-16 1980-02-28 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung
JPS567721A (en) * 1979-07-02 1981-01-27 Mochida Pharmaceut Co Ltd Preparation of immunoglobulin for intravenous injection
EP0035204B2 (en) * 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
US4495278A (en) * 1981-04-27 1985-01-22 Baxter Travenol Laboratories, Inc. Process for making novel blood clotting enzyme compositions
JPS57206608A (en) * 1981-05-29 1982-12-18 Mochida Pharmaceut Co Ltd Production of gamma-globulin for intravenous injection
FR2507332A1 (fr) * 1981-06-04 1982-12-10 Roulot Maurice Source lumineuse polychromatique munie d'un deviateur de rayons lumineux et d'un correcteur d'aberration chromatique
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
US4511556A (en) * 1982-06-10 1985-04-16 The United States Of America As Represented By The Department Of Health And Human Services Inactivation of a lipid virus
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
DE3330770A1 (de) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von humanplasma
JPS6049795A (ja) * 1983-08-31 1985-03-19 Kanai Hiroyuki 殺菌性繊維シ−ト

Also Published As

Publication number Publication date
JP2506370B2 (ja) 1996-06-12
EP0247998B1 (de) 1993-08-04
DK272287D0 (da) 1987-05-27
DK272287A (da) 1987-12-01
ATA145786A (de) 1989-11-15
EP0247998A3 (en) 1989-12-27
US4814277A (en) 1989-03-21
CA1340062C (en) 1998-09-29
EP0247998A2 (de) 1987-12-02
DE3786838D1 (de) 1993-09-09
ATE92337T1 (de) 1993-08-15
JPS62286932A (ja) 1987-12-12
AT390560B (de) 1990-05-25

Similar Documents

Publication Publication Date Title
ES2043689T3 (es) Procedimiento para la inactivacion de germenes patogenos filtrables capaces de reproducirse.
ES540919A0 (es) Procedimiento para la inactivacion de germenes patogenos filtrables,capaces de reproducirse,en productos sanguineos
FI960281A0 (fi) Menetelmä tuotteiden sterilisoimiseksi
DE3674941D1 (de) Ozonentkeimung von blut und blutprodukten.
DE58902313D1 (de) Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl.
DE69432832D1 (de) Vorrichtung und verfahren zur photoaktivierung
DK0429570T3 (da) Osteoinducerende præparater
ES532075A0 (es) Procedimiento para la inactivacion de germenes patogenos, capaces de reproducirse
DK0519901T3 (da) Virusinaktiveret blodprodukt fremstillet ved behandling med varme og/eller detergent
HUT56133A (en) Process for treating viral infections with functional derivatives of icam-1 intercellular adhesion molecule
BR8207582A (pt) Processo para producao de novas composicoes de enzima para coagulacao sang"uinea
ES2187798T3 (es) Procedimiento de conservacion de virus recombinantes infecciosos, suspension acuosa viral y su utilizacion como medicamento.
BR8706374A (pt) Processo de pasteurizacao de uma solucao aquosa de imunoglobulina
EP0733361A3 (en) Method for inactivating enveloped viruses and sperm
PT77464B (de) Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipittat
FI882129A0 (fi) Preparat med antimikrobisk verkan.
ATE298582T1 (de) Verfahren zur inaktivierung von viren und lyophilisierung von blutproteinen
DE3888571D1 (de) Stabilisierung von biologischen und pharmazeutischen Produkten während der Inaktivierung von viralen und bakteriellen Keimen.
ES2006632A6 (es) Procedimiento de tratamiento termico de fibrinogeno.
DE3689580D1 (de) Kurzzeitiges Hochtemperatur-Heizungsverfahren zur Sterilisation von hitzeempfindlichen biologischen Flüssigkeiten.
ES2044174T3 (es) Procedimiento de tratamiento de soluciones proteinicas que contienen pigmentos tales como, grupos heminicos o clorofilas en vista a su decoloracion y productos obtenidos.
FI881123A0 (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
ATE125713T1 (de) Verfahren zur inaktivierung der biologischen aktivität von dna.
FI942505L (fi) Antibakteriella aemnen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 247998

Country of ref document: ES